These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17559979

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L, Dagrada GP, Ibrahim AH, Dachs Cabanas E, Protheroe RK, Stockley DM, Orchard KH, Cross NC, Harrison CJ, Ross FM, UK Myeloma Forum.
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [Abstract] [Full Text] [Related]

  • 3. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L, Li J, Xu W, Qiu H, Zhu Y, Zhang Y, Duan L, Qian S, Lu H.
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [Abstract] [Full Text] [Related]

  • 4. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH, Abildgaard N, Plesner T, Nibe A, Nielsen O, Sørensen AG, Kerndrup GB, Leukemia/Lymphoma Study Group, Region of Southern Denmark.
    Cancer Genet Cytogenet; 2007 Apr 15; 174(2):89-99. PubMed ID: 17452249
    [Abstract] [Full Text] [Related]

  • 5. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M.
    Blood; 1997 Jul 15; 90(2):526-34. PubMed ID: 9226151
    [Abstract] [Full Text] [Related]

  • 6. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
    Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, Granzow M, Raab MS, Ho AD, Goldschmidt H, Hose D.
    J Clin Oncol; 2013 Dec 01; 31(34):4325-32. PubMed ID: 24145347
    [Abstract] [Full Text] [Related]

  • 7. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF.
    Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290
    [Abstract] [Full Text] [Related]

  • 8. [Application of fluorescence in-situ hybridization technique in multiple myeloma].
    Zhao Y, Zheng D, Li J, Zhu WT.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep 01; 38(5):459-64. PubMed ID: 19830857
    [Abstract] [Full Text] [Related]

  • 9. 1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
    Grzasko N, Hus M, Chocholska S, Pluta A, Hajek R, Dmoszynska A.
    Leuk Lymphoma; 2012 Dec 01; 53(12):2500-3. PubMed ID: 22497640
    [No Abstract] [Full Text] [Related]

  • 10. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
    Xu W, Li JY, Fan L, Chen LJ, Qiu HR, Qiu HX, Lu H.
    Int J Lab Hematol; 2009 Jun 01; 31(3):338-43. PubMed ID: 18284415
    [Abstract] [Full Text] [Related]

  • 11. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL, Grosbois B, Bataille R.
    Cancer Res; 1999 Sep 15; 59(18):4546-50. PubMed ID: 10493504
    [Abstract] [Full Text] [Related]

  • 12. Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.
    Bang SM, Kim YR, Cho HI, Chi HS, Seo EJ, Park CJ, Yoo SJ, Kim HC, Chun HG, Min HC, Oh BR, Kim TY, Lee JH, Lee DS.
    Cancer Genet Cytogenet; 2006 Jul 15; 168(2):124-32. PubMed ID: 16843102
    [Abstract] [Full Text] [Related]

  • 13. Plasma cell labeling index correlates with deletion of 13q14 in multiple myeloma.
    Li C, Chen L, Gao X, Qu X, Shen W, Yang R, Zhang R, Qiu H, Xu J, Lu H, Li J.
    Leuk Lymphoma; 2011 Feb 15; 52(2):260-4. PubMed ID: 21133734
    [Abstract] [Full Text] [Related]

  • 14. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A, Osier DG, Orchard KH.
    Br J Haematol; 2003 Mar 15; 120(6):944-52. PubMed ID: 12648063
    [Abstract] [Full Text] [Related]

  • 15. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY, Huang JW, Zhang J, Du HP, Jiang H, Li JY, Xue YQ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec 15; 24(6):685-8. PubMed ID: 18067084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
    Chng WJ, Santana-Dávila R, Van Wier SA, Ahmann GJ, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Jacobus S, Blood E, Oken MM, Henderson K, Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A, Greipp PR, Fonseca R.
    Leukemia; 2006 May 15; 20(5):807-13. PubMed ID: 16511510
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Investigation of the molecular changes in patients with multiple myeloma by fluorescence in situ hybridization].
    Yang RF, Li CM, Chen LJ, Qiu HR, Yang H, Liu P, Xu JR, Li JY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct 15; 27(5):567-70. PubMed ID: 20931539
    [Abstract] [Full Text] [Related]

  • 20. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R, Zojer N, Ackermann J, Krömer E, Kittler H, Fritz E, Kaufmann H, Nösslinger T, Riedl L, Gisslinger H, Jäger U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J.
    J Clin Oncol; 2000 Feb 15; 18(4):804-12. PubMed ID: 10673522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.